Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what steps he is taking to made the drug Everolimus available on the NHS for treating the subependymal giant cell astrocytoma form of tuberous sclerosis complex.

A policy for the provision of Everolimus for Tuberous Sclerosis forComplex Related Renal Angiomyolipoma anda policy for the provision of Everolimusfor SubependymalGiant Cell Astrocytoma are currently in development. Once completed, each policy will need to be considered by the relevant clinical panels, the Clinical Priorities Advisory Group and the Specialised Commissioning Oversight Group.

It is NHS England’s intention that the policies will be published by the end of the financial year.